Clinical Trials on Hematologic Test in New Zealand
Total 2762 results
-
Sight DiagnosticsCompleted
-
Essenlix CorporationCompletedHematologic TestsUnited States
-
Accriva DiagnosticsUnknownBlood Coagulation TestUnited States
-
Malaghan Institute of Medical ResearchRecruitingLymphoma | Leukemia | Myeloma | Temperature Change, Body | Haematological MalignancyNew Zealand
-
University of SydneyUniversity of Roma La Sapienza; Australasian Bone Marrow Transplant Recipient... and other collaboratorsRecruiting
-
Russell Sage CollegeCompleted
-
City University of New York, School of Public HealthNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingTest Acceptability/Usability of a Physical Activity App Developed for African American WomenUnited States
-
NYU Langone HealthCompleted
-
Zealand University HospitalUnknownHematological CancerDenmark
-
NYU Langone HealthWithdrawnCancer | Hematological MalignancyUnited States
-
Smart Immune SASRecruitingHematological MalignanciesUnited States
-
Albert Einstein College of MedicineRecruiting
-
University of Auckland, New ZealandLeukaemia & Blood Cancer New ZealandActive, not recruiting
-
Orsenix LLCCompleted
-
Novartis PharmaceuticalsCompletedCancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological MalignanciesUnited States
-
Chinese University of Hong KongCompletedIntention to Get SARS-CoV-2 Vaccination | Intention to Get SARS-CoV-2 Antibody TestHong Kong
-
AlexionAchillion, a wholly owned subsidiary of AlexionCompletedParoxysmal Nocturnal HemoglobinuriaNew Zealand, Korea, Republic of, Italy
-
Apellis Pharmaceuticals, Inc.CompletedParoxysmal Nocturnal HemoglobinuriaHong Kong, Thailand, New Zealand, Malaysia
-
Esanex Inc.Completed
-
Hangzhou Sumgen Biotech Co., Ltd.RecruitingSG2501 Safety Study in Subjects With Relapsed or Refractory Hematological Malignancies and Lymphoma.Lymphoma | Hematological MalignancyUnited States
-
Kite, A Gilead CompanyEnrolling by invitationSolid and Hematological MalignanciesUnited States, Netherlands, Japan, Australia, France, Israel, Germany, Canada, United Kingdom
-
SanofiCompletedHematological MalignancyGreece, Spain, Peru, Israel, United States, Argentina, Belgium, Brazil, Chile, Finland, France, Italy, Mexico, Russian Federation, Turkey, Ukraine, United Kingdom
-
HutchmedRecruitingIsocitrate Dehydrogenase Gene MutationSpain, United States
-
Yale UniversityEnrolling by invitationCoronary Disease | Percutaneous Coronary Intervention | Cardiac Catheterization | Myocardial Perfusion Imaging | Exercise TestUnited States
-
Kangpu Biopharmaceuticals, Ltd.RecruitingHematological MalignanciesUnited States
-
AdaptimmuneRecruitingSolid and Hematological MalignanciesUnited States, Spain, Canada, United Kingdom
-
IncuronTerminatedHematological MalignanciesUnited States
-
Karyopharm Therapeutics IncCompletedHematological MalignanciesUnited States, Denmark, Canada
-
AstraZenecaActive, not recruitingPediatric Cancer | Hematological Malignancies | Solid Tumor PediatricSpain, Italy, United States, United Kingdom, France, Netherlands, Germany
-
Memorial Sloan Kettering Cancer CenterCompletedLymphoma | Leukemia | Myelodysplastic SyndromeUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedLymphoma | Acute Myeloid Leukemia | Leukemia | Myelodysplastic Syndrome | Myeloma | Hematological MalignancyUnited States
-
Alexion PharmaceuticalsAchillion, a wholly owned subsidiary of AlexionCompletedParoxysmal Nocturnal Hemoglobinuria (PNH)United Kingdom, New Zealand, Korea, Republic of, Italy
-
GlaxoSmithKlineCompletedPurpura, Thrombocytopaenic, IdiopathicUnited States, Australia, New Zealand
-
TakedaAffymaxCompletedAnemiaUnited States, New Zealand, Australia, Italy, United Kingdom
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple MyelomaUnited States, New Zealand
-
AstraZenecaRecruitingHematological MalignanciesUnited States, Spain, Korea, Republic of, Italy, Japan, Taiwan, Australia, Germany, China
-
Gilead SciencesTerminatedHematological MalignanciesUnited States, United Kingdom
-
Effector TherapeuticsTerminated
-
Matthew DallosBristol-Myers SquibbTerminatedSolid Tumor | Sars-CoV2 | Hematological MalignancyUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingHematological MalignanciesUnited States, Canada, Brazil, Chile, Denmark, France, Germany, Hungary, Israel, Italy, Poland, Russian Federation, Spain, Taiwan, Turkey, Ukraine
-
PfizerTerminatedHealthy | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Primary Immune ThrombocytopeniaSpain, United States, Belgium, United Kingdom, New Zealand
-
Synta Pharmaceuticals Corp.CompletedLymphoma | Leukemia | Hematological Malignancies | Metastatic or Unresectable Solid TumorsUnited States
-
PfizerTerminatedHemophilia AUnited States, New Zealand
-
University Hospital of CologneRadboud University Medical CenterCompletedInvasive AspergillosisGermany, Netherlands
-
Protalex, Inc.TerminatedPhase I Safety and Tolerability Study of Staphylococcal Protein A in Adult Patients With Chronic ITPIdiopathic Thrombocytopenic Purpura (ITP)Australia, New Zealand
-
NYU Langone HealthActive, not recruitingHematologic MalignancyUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Alla KeyznerCompletedMyelodysplastic Syndromes | Hodgkin Lymphoma | Non-Hodgkin Lymphoma | Acute Leukemia in Remission | Hematological Malignancy | Acute Lymphoblastic Leukemia in RemissionUnited States
-
Ruhr University of BochumCompletedTest the Efficacy of Antiplatelet Regimes in Acute StrokeGermany
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingSolid Tumor | Hematologic Malignancy | Solid Tumor, Adult | Solid CarcinomaUnited States